ASCO 2019 ANNUAL MEETING

ASCO 2019 ANNUAL MEETING

INTERVIEW WITH EVAN YU
Management of mCRPC using Sipuleucel-T

VIEW ALL mCRPC VIDEOS

ASCO 2019 ANNUAL MEETING

ASCO 2019 ANNUAL MEETING

INTERVIEW WITH JACOB BERCHUCK & MARY-ELLEN TAPLIN
Genetic Risk in Prostate Cancer

VIEW ALL PROSTATE CANCER VIDEOS

ASCO 2019 ANNUAL MEETING

ASCO 2019 ANNUAL MEETING

INTERVIEW WITH KARIM FIZAZI
ARAMIS Trial in Prostate Cancer: Impact of Darolutamide on Pain and Quality of Life

VIEW ALL nmCRPC VIDEOS

EAU 2019 ANNUAL MEETING

EAU 2019 ANNUAL MEETING

INTERVIEW WITH THOMAS POWLES
Immunotherapy in the Peri-Operative Setting for Bladder Cancer

VIEW ALL BLADDER CANCER VIDEOS

Videos
State-of-the-industry video lectures by leading urology experts
Featured Videos

#WCE2014 - Urinary incontinence after laser prostatectomy for BPH – contemporary experience - Interview

TAIPEI, TAIWAN (UroToday.com) - Introduction and Objectives: Over the past decade, there has been a dramatic shift in endoscopic treatment of lower urinary tract symptoms (LUTS) favoring laser technologies. Urinary incontinence (UI) after laser surgery has not been described.

wceMethods: Retrospective cohort of 55 men (mean age 67) who underwent Greenlight laser prostatectomy for BPH. We administered International Prostatic Symptoms Score (IPSS) and Michigan Incontinence Symptom Index (MISI) at baseline (preoperatively) and after the surgery. We estimated the incidence, severity, and bother, of incontinence using the MISI at 1 and 6 months after surgery.We then fitted multivariable regression model to examine the factors associated with the change in UI.

Results: MISI scores at baseline, 1 month and 6 month after surgery demonstrates slight increase in UI at 1 month and then an average UI that is lower than baseline at 6 months. Urge urinary incontinence (MISI-UUI) was predominant before surgery. The proportion of patients who had the minimally importance difference (MID) at 6 months after the surgery is 16%, 12%, 10%, and 3% for the total severity, UUI, SUI, and bother domains, respectively. Adjusted regression found higher baseline MISIUUI and IPSS obstructive domain score (r = 0.4, p = 0.008) to be predictive of a change in UI.

Conclusions: UI was present at baseline but improved by 6 months. Although 16% of the patients had the MID of urinary incontinence, only 3% were bothered by their symptoms. Greater MISI-UUI score and obstructive symptoms at baseline were both associated with less UI after surgery.

Source of Funding: None

 
Listen to an interview with Abdulrahman Alruwaily, one of the authors of this study.

 

Presented by Abdulrahman Alruwaily, Rabia Siddiqui, Maggie Bierlein, Heather Crossley, Sara Lenherr, and John Wei at the 32nd World Congress of Endourology & SWL - September 3 - 7, 2014 - Taipei, Taiwan

University of Michigan Medical School, Ann Arbor, MI USA

 

 

Conference Coverage
 
Recent data from conferences worldwide
Journals
Publications focusing on urologic cancer treatments through original manuscripts
Everyday Urology Volume 4 Issue 1

Everyday Urology™ - Oncology Insights

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe